[1]
|
Siegel R, Ma J, Zou Z, et al. Cancer statistics[J].CA Cancer J Clin, 2014;64:9-29
|
[2]
|
李鸣,张思维,马建辉,等.中国部分市县前列腺癌发病趋势比较研究[J].中华泌尿外科杂,2009,30(6):368-370
|
[3]
|
韩苏军,张思维,陈万青,等.中国前列腺癌发病现状和流行趋势分析[J].临床肿瘤杂志,2013,18(4):330-334
|
[4]
|
Akhilesh P, Sharad G, Bhavesh M, et al. Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: Emerging role and concepts[J].Biomed Res Int, 2013:107954
|
[5]
|
Lemen R A, Lee J S, Wagoner J K, et al. Cancer mortality among cadmium production workers[J].Ann NY Acad Sci, 1976, 271:273-279
|
[6]
|
Dubrow R, Wegman D H. Cancer and occupation in Massachusetts: A death certificate study[J].Am J Ind Med, 1984, 6(3):207-230
|
[7]
|
Elghany N A, Schumacher M C, Slattery M L, et al. Occupation, cadmium exposure, and prostate cancer[J].Epidemiology, 1990, 1(2):107-115
|
[8]
|
West DW, Slattery M L, Robison L M, et al. Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors[J].Cancer Causes Control, 1991, 2(2):85-94
|
[9]
|
IARC. Cadmium and cadmium compounds[J]. IARC Monogr Eval Carcinog Risk Hum.1993, 58:119-237
|
[10]
|
Hartwig A. Cadmium and cancer[J].Met Ions Life Sci, 2013, 11:491-507
|
[11]
|
Straif K, Brahim-Tallaa L, Baan R, et al. A Review of human carcinogens-part C: Metals, arsenic, fibres, and dusts, and fibres[J].Lancet Oncol, 2009,10(5):453-454
|
[12]
|
Aimola P, Carmignani M, Volpe A R, et al. Cadmium induces p53-dependent apoptosis in human prostate epithelial cells[J].PLoS One, 2012, 7(3):e33647
|
[13]
|
Achanzar W E, Achanzar K B, Lewis J G, et al. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis[J].Toxicol Appl Pharmacol, 2000, 164(3):291-300
|
[14]
|
Bakshi S, Zhang X, Godoy-Tundidor S, et al. Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: Oncogenic and immunomodulations involving the action of tumor necrosis factor[J].Environ Health Perspect, 2008, 116(6):769-776
|
[15]
|
Julin B, Wolk A, Johansson J E, et al. Dietary cadmium exposure and prostate cancer incidence: A population-based prospective cohort study[J].Br J Cancer, 2012, 107(5);895-900
|
[16]
|
Huff J, Lunn R M, Waalkes M P, et al. Cadmium-induced cancers in animals and in humans[J].Int J Occup Environ Health, 2007,13(2):202-212
|
[17]
|
Qu W, Ke H, Pi J, et al. Acquisition of apoptotic resistance in cadmium-transformed human prostate epithelial cells: Bcl-2 overexpression blocks the activation of jnk signal transduction pathway[J].Environ Health Perspect, 2007, 115(7):1094-1100
|
[18]
|
Achanzar W E, Webber M M, Waalkes M P. Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human prostate epithelial cells[J].Prostate, 2002, 52(3):236-244
|
[19]
|
Bello D, Webber M M, Kleinman H K, et al. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18[J].Carcinogenesis, 1997, 18(6): 1215-1223
|
[20]
|
Kharbanda S, Saxena S, Yoshida K, et al. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage[J].J Biol Chem, 2000, 275(1): 322-327
|
[21]
|
Tournier C, Hess P, Yang D D, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway[J].Science, 2000, 288(5467):870-874
|
[22]
|
Vogelstein B, Lane D, Levine A J. Surfing the p53 network[J].Nature. 2000, 408(6810):307-310
|
[23]
|
Lag M, Westly S, Lerstad T, et al. Cadmium induced apoptosis of primary epithelial lung cells: Involvement of Bax and p53, but not oxidative stress[J].Cell Biol Toxicol. 2002;18(1): 29-42
|
[24]
|
Son Y O, Lee J C, Hitron J A, et al. Cadmium induces intracellular Ca2+ and H2O2-dependent apoptosis through JNK- and P53- mediated pathways in skin epithelial cell line[J].Toxicol Sci, 2010, 113(1):127-137
|
[25]
|
Yu X, Sidhu J S, Hong S, et al. Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquinated proteins, and apoptosis in mouse embryonic fibroblast cells[J].Toxicol Sci, 2011, 120(2):403-412
|
[26]
|
Deiry W S, Tokino T, Velculescu V E, et al. WAF1, a potential mediator of p53 tumor suppression[J].Cell, 1993, 75(4): 817-825
|
[27]
|
McEleny K R, Watson R W, Coffey R N, et al. Inhibitors of apoptosis proteins in prostate cancer cell lines[J].Prostate, 2002, 51(2):133-140
|
[28]
|
Bosland M C. The role of steroid hormones in prostate carcinogenesis[J].J Natl Cancer Inst, 2000, 27:39-66
|
[29]
|
Ellem S J, Risbridger G P. Aromatase and regulating the estrogen: Androgen ratio in the prostate gland[J].J Steroid Biochem Mol Biol, 2010, 118(4/5):246-251
|
[30]
|
Benbrahim-Tallaa L, Liu J, Webber M M, et al. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells[J].Prostate, 2007, 67(2):135-145
|
[31]
|
Stoica A, Katzenellenbogen B S, Martin M B. Activation of estrogen receptor-alpha by the heavy metal cadmium[J].Mol Endocrinol, 2000, 14(4):545-553
|
[32]
|
Johnson M D, Kenney N, Stoica A, et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland[J].Nat Med, 2003, 9(8):1081-1084
|
[33]
|
Lai J S, Brown L G, True L D, et al. Metastases of prostate cancer express estrogen receptor-beta[J].Urology, 2004, 64(4):814-820
|
[34]
|
Sahlin L. Dexamethasone attenuates the estradiol-induced increase of IGF-1 mRNA in the rat uterus[J].J Steroid Biochem Mol Biol, 1995, 55(1):9-15
|
[35]
|
Kaaks R, Lukanova A, Sommersberg B. Plasma androgens, IGF-1, body size, and prostate cancer risk: A synthetic review[J].Prostate Cancer Prostatic Dis, 2000, 3(3):157-172
|
[36]
|
Burfeind P, Chernicky C I, Rininsland F, et al. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo[J].Proc Natl Acad Sci USA, 1996, 93(14):7263-7268
|
[37]
|
Bollati V, Baccarelli A. Environmental epigenetics[J].Heredity(Edinb), 2010, 105(1):105-112
|
[38]
|
Suganuma T, Workman J L. Crosstalk among Histone Modification[J].Cell, 2008, 135(4):604-607
|
[39]
|
Fauque P, Jouannet P, Lesaffre C, et al. Assisted reproductive technology affects developmental kinetics, H19 imprinting control region methylation and H19 gene expression in individual mouse embryos[J].BMC Dev Biol, 2007, 7(1):116
|
[40]
|
Ren X, Mchale C M, Skibola C F, et al. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis[J].Environ Health Perspect, 2011, 119(1):11-19
|
[41]
|
Hou L, Zhang X, Wang D, et al. Environmental chemical exposures and human epigenetics[J].Int J Epidemiol, 2012, 41(1):79-105
|
[42]
|
Severson P L, Tokar E J, Vrba L, et al. Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation[J].Epidenetics, 2012, 7(11):1238-1248
|
[43]
|
Kristensen L S, Nielsen H M, Hansen L L. Epigenetics and cancer treatment[J].Eur J Pharmacol, 2009, 625(1/3):131-142
|
[44]
|
Rauch T, Wang Z, Zhang X, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay[J].Proc Natl Acad Sci USA, 2007, 104(13):5527-5532
|
[45]
|
Novak P, Jensen T, Oshiro M M, et al. Agglomerative epigenetic aberrations are a common event in human breast cancer[J].Cancer Res, 2008, 68(20):8616-8625
|
[46]
|
Novak P, Jensen T, Oshiro M M, et al. Epigenetic inactivation of the HOXA gene cluster in breast cancer[J].Cancer Res, 2006, 66(22):10664-10670
|
[47]
|
Coolen M W, Stirzaker C, Song J Z, et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing(LRES) reduces transcriptional plasticity[J].Nat Cell Biol, 2010, 12(3):235-246
|
[48]
|
IARC. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum[J].2004, 84:269-477
|
[49]
|
Ferreccio C, Smith A H, Duran V, et al. Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed northern Chile[J].Am J Epidemiol,2013, 178(5):813-818
|
[50]
|
Garcia-Esquinas E, Pollan M, Umans J G, et al. Arsenic exposure and cancer mortality in a US-based prospective cohort: The strong heart study[J].Cancer Epidemiol Biomarkers Prev, 2013, 22(11):1944-1953
|
[51]
|
Benbrahim-Tallaa L, Waalkes M P. Inorganic arsenic and human prostate cancer[J].Environ Health Perspect, 2008, 116(2):158-164
|
[52]
|
Yang C Y, Chang C C, Chiu H F. Dose arsenic exposure increase the risk for prostate cancer?[J].J Toxicol Environ Health A, 2008, 71(23):1559-1563
|
[53]
|
Wallace D C. Mitochondrial diseases in man and mouse[J].Science, 1999, 283(5407):1482-1488
|
[54]
|
Barchosky A, Klei L R, Dudek E J, et al. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite[J].Free Radical Biol Med, 1999, 27(11/12):1405-1412
|
[55]
|
Liu S X, Athar M, Lippai I, et al. Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity[J].Proc Natl Acad Sci USA, 2001, 98(4):1643-1648
|
[56]
|
Singh K P, Kumari R, Treas J, et al. Chronic exposure to arsenic causes increased cell survival, DNA damage, and increased expression of mitochondrial transcription factor A(mtTFA) in human prostate epithelial cells[J].Chem Res Toxicol, 2011, 24(3):340-349
|
[57]
|
Jaenisch R, Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals[J].Nat Genet, 2003, 33:245-254
|
[58]
|
Laird P W, Jaenisch R. DNA methylation and cancer[J].Hum Mol Genet, 1994, 3:1487-1495
|
[59]
|
Benbrahim-Tallaa L, Waterland R A, Styblo M, et al. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: Aberrant genomic DNA methylation and K-ras oncogene activation[J].Toxicol Appl Pharmacol, 2005, 206(3):288-298
|
[60]
|
Iqbal J, Chong P Y, Tan P H. Breast cancer stem cells: An update[J].J Clin Pathol, 2013, 66(6):485-490
|
[61]
|
Ricci-vitian L, Lombardi D G, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells[J].Nature, 2007, 445(7123):111-115
|
[62]
|
Li C, Heidt D G, Dalerba P, et al. Identification of pancreatic cancer stem cells[J].Cancer Res, 2007, 67(3):1030-1037
|
[63]
|
Lee T K, Castilho A, Cheung V C, et al. CD24+ liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation[J].Cell Stem Cell, 2011, 9(1):50-63
|
[64]
|
Curtis S J, Sinkevivius K W, Li D, et al. Primary tumor genotype is an important determinant in identification of lung cancer propagating cells[J].Cell Stem Cell, 2010, 7(1):127-133
|
[65]
|
Tokar E J, Diwan B A, Waalkes M P, et al. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype[J].Environ Health Perspect, 2010, 118(1):108-115
|
[66]
|
Xu Y, Tokar E J, Sun Y, et al. Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype[J].Environ Health Perspect, 2012, 120(6):865-871
|
[67]
|
Tisato F, Marzano C, Porcbia M, et al. Copper in diseases and treatments, and copper-based anticancer strategies[J].Med Res Rev, 2010, 30(4):708-749
|
[68]
|
Karimi G, Shahar S, Homayouni N, et al. Association between trace element and heavy metal levels in hair and nail with prostate cancer[J].Asian Pac J Cancer Prev, 2012, 13(9):4249-4253
|
[69]
|
Hayashida K, Bartlett A H, Chen Y, et al. Molecular and cellular mechanisms of ectodomain shedding[J].Anat Rec(Hoboken), 2010, 293(6):925-937
|
[70]
|
Duffy M J, Mullooly M, O'Donovan N, et al. The ADAMs family of proteases: New biomarkers and therapeutic targets for cancer?[J].Clin Proteomics, 2011, 8(1):9
|
[71]
|
Hua H, Li M, Luo T, et al. Matrix metalloproteinases in tumorigenesis: An evolving paradigm[J].Cell Mol Life Sci, 2011, 68(23):3853-3868
|
[72]
|
Parr-Sturgess C A, Tinker C L, Hart C A, et al. Copper modulates zinc metalloproteinase-dependent ectodomain shedding of key signaling and adhesion proteins and promotes the invasion of prostate cancer epithelial cells[J].Mol Cancer Res, 2012, 10(10):1282-1293
|
[73]
|
Ozmen H, Erulas F A, Karatas F, et al. Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer[J].Clin Chem Lab Med, 2006, 44(2):175-179
|
[74]
|
Lu N, Zhou H, Lin Y H, et al. Oxidative stress mediates CoCl(2)-induced prostate tumour cell adhesion: role of protein kinase C and p38 mitogen-activated protein kinase[J].Basic Clin Pharmacol Toxicol, 2007, 101(1):41-46
|
[75]
|
Tsui K H, Chang P L, Juang H H. Manganese antagonizes iron blocking mitochondrial aconitase expression in human prostate carcinoma cells[J].Asian J Androl, 2006, 8(3):307-315
|
[76]
|
Yaman M, Atici D, Bakirdere S, et al. Comparison of trace metal concentrations in malign and benign human prostate[J].J Med Chem, 2005, 48(2):630-634
|